comparing the effect two drugs, moxonidine and clonidine, on reducing pain and other properties of spinal nerve block
Not Applicable
- Conditions
- Health Condition 1: K40-K46- HerniaHealth Condition 2: S70-S79- Injuries to the hip and thighHealth Condition 3: S80-S89- Injuries to the knee and lower leg
- Registration Number
- CTRI/2021/11/038087
- Lead Sponsor
- Shreyas S Bhat
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
a)Patients who are willing to give written informed consent
b)Patients posted for infraumbilical surgeries.
c)Age group- 18- 60 years, of either sex.
d)American Society of Aneaesthesiologists (ASA) grade 1 and 2
e)Weight 50-80 kg.
f)Height 150 cm to 180 cm.
Exclusion Criteria
Patients who are not willing to give informed written consent for study.
b)Allergy to local anesthetics
c)Uncontrolled diabetes mellitus, hypertension, cardiac disorders, neuropathies, patients with chronic analgesic use, psychiatric medications.
d)Pregnancy.
e)Contraindications/relative contraindications to spinal anaesthesia.
Hypovolemic shock, Bleeding diathesis and coagulopathy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Onset of sensory blockade of subarchnoid block, 2 segment regression time, duration of analgesia postoperativelyTimepoint: Onset of sensory blockade checked every 2 minute till maximum level is acheived, 2 segment regression time, duration of analgesia is assesed 30 min, 1 hour, and then 2nd hourly for 24 hours
- Secondary Outcome Measures
Name Time Method Motor characteristics of motor blockade, hemodynamic parameters.Timepoint: duration of motor blockade assesed every two minutes till max motor blockade,hemodynamics assesed every five minutes intraoperatively and every hour postoperatively for 24 hours.